UNSPSC 51373321: Aspirin/propoxyphene

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN101. This VA Drug Class (CN101) classifies this compound as belonging to the group OPIOID ANALGESICS.

UNSPSC 51373321 Aspirin/propoxyphene is a Commodity code, but state and local governments are not currently soliciting aspirin or propoxyphene under it. The three recent opportunities tagged to this code are instead purchasing naloxone and drug deactivation systems, therapeutic pharmacy direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and over-the-counter products through cooperative purchasing. The code's nominal scope does not align with actual recent procurement activity, suggesting either a misclassification in how opportunities are being tagged or minimal legitimate demand for aspirin and propoxyphene through formal state and local channels.

Geographic activity appears concentrated in the South and Upper Midwest. Seminole County, Florida issued an IFB (IFB60459723LAS, due July 26, 2023) for naloxone and drug deactivation systems with annual volumes of 1,900 units and 800 systems respectively, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The Texas Health and Human Services Commission posted an RFI (HHS0017013, issued March 27, 2026) exploring direct-to-manufacturer prescription programs to improve fulfillment efficiency outside traditional pharmacy benefit manager arrangements. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers—AmerisourceBergen (Cencora), Cardinal Health 110 and 112, and Morris & Dickson—with contract awards effective July 1, 2026. Issuing bodies include a county health department, a state HHS commission, and a multistate cooperative purchasing entity, reflecting the diversity of pharmaceutical procurement across health and human services jurisdictions.